Liminatus Pharma, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 12611 HIDDENCREEK WAY, CERRITOS, CA, 90703
Mailing Address 12611 HIDDENCREEK WAY, CERRITOS, CA, 90703
Phone 213-273-5453
Fiscal Year End 1231
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 8-K Current report of material events | January 26, 2026 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | October 6, 2025 | View on SEC |
| 8-K Current report of material events | August 25, 2025 | View on SEC |
| 3 Initial insider ownership report | August 15, 2025 | View on SEC |
| 8-K Current report of material events | August 14, 2025 | View on SEC |
| S-1/A IPO registration amendment | July 28, 2025 | View on SEC |
Material Events
8-K Legal Issue February 9, 2026
High Impact
- Liminatus Pharma resolved a major legal dispute with Clear Street LLC.
- The company avoided a substantial cash payment of over $8 million by issuing stock.
8-K Financial Distress January 26, 2026
High Impact
- Liminatus has 180 calendar days to regain Nasdaq compliance.
- Potential strategies for compliance include reverse stock split, positive clinical trial results, strategic partnerships, or a successful capital raise.
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.